111, Inc. (NASDAQ:YI – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 85,300 shares, an increase of 167.4% from the December 31st total of 31,900 shares. Based on an average daily volume of 216,500 shares, the short-interest ratio is currently 0.4 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 111 in a research note on Saturday, January 18th.
Read Our Latest Research Report on 111
111 Stock Up 3.4 %
111 (NASDAQ:YI – Get Free Report) last released its earnings results on Wednesday, November 27th. The company reported ($0.20) earnings per share for the quarter.
111 Company Profile
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Stories
- Five stocks we like better than 111
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.